SCHEMBL8467720

SCHEMBL8467720

CC(C)(C)OC(=O)NC/C=C/c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.49
CTSS P25774 4/20 0.45
CTSK P43235 3/20 0.45
PAM P19021 1/20 0.45
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
IDO1 P14902 1/20 0.44
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
EGFR P00533 1/20 0.43
KDM4A O75164 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
SYK P43405 1/20 0.42
PTPN11 Q06124 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5158237 1.00 MAOB (0.49) MAOBCTSSCTSKPAMNFKB1
SCHEMBL5638589 0.87 MAPT (0.56) EGFRPTPN11NPC1RAB9AALDH1A1
SCHEMBL5638591 0.87 MAPT (0.56) EGFRPTPN11NPC1RAB9AALDH1A1
SCHEMBL14499624 0.87 MAPT (0.56) EGFRPTPN11NPC1RAB9AALDH1A1
SCHEMBL5682372 0.85 IDO1 (0.48) CTSSCTSKPAMNFKB1NFKB2
SCHEMBL5678372 0.85 IDO1 (0.48) CTSSCTSKPAMNFKB1NFKB2
SCHEMBL5678361 0.85 IDO1 (0.48) CTSSCTSKPAMNFKB1NFKB2
SCHEMBL31602191 0.85 MAOA (0.48) MAOBIDO1EGFRCA12CA1
SCHEMBL31022932 0.85 TTR (0.45) KDM4ANPC1RAB9A
SCHEMBL7453149 0.84 NFKB1 (0.46) CTSSCTSKNFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881002-A1 HCV NS-3 serine protease inhibitors Tibotec Pharmaceuticals Ltd. (IE) 2008-01-23 EP disclosed
EP-1881001-A1 HCV NS-3 serine protease inhibitors Tibotec Pharmaceuticals Ltd. (IE) 2008-01-23 EP disclosed